Call for Abstract
5th International Congress on Bacteriology and Infectious Diseases, will be organized around the theme “Current Concepts and Diagnosis in Bacteriology & Infectious Diseases”
Bacteriology 2017 is comprised of 13 tracks and 211 sessions designed to offer comprehensive sessions that address current issues in Bacteriology 2017.
Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.
Register now for the conference by choosing an appropriate package suitable to you.
Bacterial ecology is defined as the interaction between bacteria and with their environment. Bacteria play a vital role in the biosphere and certain key processes, such as, the production and oxidation of methane, soil formation, conversion of rock to soil etc. Bacteria are single-celled microorganisms and the part of microbiological science which encompasses the study of bacteria is known as “Bacteriology”. Major researches in bacteriology over the past years resulted in the development of many useful vaccines. The ancestors of present bacteria were said to be first forms of life on earth. Bacterial cells are about 0.5-5.0 micrometres in length. Bacteria exists in different shapes like single celled, diploid (Neisseria), chains (Streptococcus), filaments (Actinobacteria).Bacteria lack membrane bound organelles, contains single loop DNA, it generally undergo conjugation. There are techniques like staining to differentiate Gram positive and Gram negative bacteria. Compared to virus, cost for antibiotics is low still 700 million infections were found every year with the mortality rate of 0.1% normally and in severe conditions it is about 25%.
The global Clinical Bacteriology market is valued at $6,727.29 million in 2014 and is expected to grow at a CAGR of 13.03% between 2014 and 2019. Increasing disease burden of infectious diseases and increased funding for healthcare expenditure are the important growth drivers for this market during the forecast period.
- Track 1-1Bacteriophage ecology, history, and behaviour
- Track 1-2Human colonic microbiota
- Track 1-3Morphological plasticity as a bacterial survival strategy
- Track 1-4human-Bacteroides thetaiotaomicron symbiosis
- Track 1-5biology of microorganisms
- Track 1-6Mutations of bacteria
- Track 1-7Metabolism and biochemical characteristics of yogurt bacteria
- Track 1-8Survival strategies of bacteria in the natural environment
- Track 1-9Metabolism of single carbon compounds
- Track 1-10Aerobic anoxygenic phototrophic bacteria
- Track 1-11The extracellular polysaccharides of bacteria
- Track 1-12normal bacterial flora
- Track 1-13The L forms of bacteria
- Track 1-14Fluorescence in situ hybridization
- Track 1-15 Molecular mechanisms of bacterial pathogenesis
- Track 1-16Target Drug Interactions, Medication and Validation
- Track 1-17 Bacterial secretion and effectors systems
- Track 1-18 Discovery of Antibiotics
- Track 1-19Bacterial signal transduction networks
- Track 1-20Bacterial genomics and regulation
- Track 1-21 Nutrition: Growth and control of bacteria
- Track 1-22 Bacterial cell morphology & bacterial manipulation of host physiology and innate immune responses
- Track 1-23 Microbe-Host Interactions as virulence determinants
- Track 1-24bacterial relationships in the gut
- Track 1-25Microbial metabolism of polycyclic aromatic hydrocarbons
- Track 1-26Role of nutrients and bacterial colonization
Clinical Reviews of infectious diseases supports the diagnosis of disease using laboratory testing of blood, tissues, and other body fluids. There are types of specimens used clinical pathology. They are blood, urine, sputum, faeces, and other body fluids, in which it deals with health care for women, especially the diagnosis and treatment of disorders affecting the female reproductive system.
The market is segmented on the basis of geography, such as, North America, Europe, Asia-Pacific and Rest of the World. At present, North America and Europe are the most prominent markets, owing to growing prevalence of various gram-positive bacterial infections and associated diseases. However, Asia-Pacific and some countries in Rest of the World region are expected to show lucrative growth in upcoming period, owing to rapidly growing prevalence and awareness about the diseases caused due to gram-positive bacteria and their chronic effects.
The value of microbials market is projected to increase to $4,456.37 million by 2019 at a CAGR of 15.3% from 2014. The market is expected to show a prominent growth during the forecast period 2014 – 2020.
- Track 2-1 Bacteria in blood for transfusion
- Track 2-2treatment of bacterial conjunctivitis
- Track 2-3Bacterial adherence to biomaterials and tissue
- Track 2-4bacterial endocarditis
- Track 2-5Antimicrobial use and bacterial resistance
- Track 2-6clinical microbiology with bacterial genome sequencing
- Track 2-7Bacterial keratitis
- Track 2-8Bacterial and fungal biofilm infections
- Track 2-9Neutrophil and eosinophil granulocytes in bacterial infection
- Track 2-10Infective endocarditis
- Track 2-11Fungal—bacterial interactions
- Track 2-12Bacterial diversity in human subgingival plaque
- Track 2-13Clinical implications and microbiology of bacterial persistence
- Track 2-14Bacterial Infection Rates After Liver Transplantation
- Track 2-15Human aeromonas infections
- Track 2-16Joint infection by anaerobic bacteria
- Track 2-17Papillon-Lefevre syndrome
- Track 2-18 Pyomyositis
- Track 2-19Enterobacter sakazakii infections
- Track 2-20Urinary Tract Infections
- Track 2-21 Bacterial vaginosis
- Track 2-22bacterial meningitis
- Track 2-23Prevention of bacterial endocarditis
- Track 2-24Bacterial translocation
- Track 2-25Clinical microbiology of bacterial and fungal sepsis
Identification is the practical application of taxonomic knowledge. The control of microbial growth involves microscopy of microbes and sterilization, disinfection, sanitization processes or use of chemical agents. Pathogenic bacteria are bacteria which are capable of causing disease when enters into the body which can spread through water, air, soil and also through physical contact.
For the Diagnosis of Pathogenic microorganisms, the direct examination and techniques includes Immunofluorescence, immuno-peroxidase staining, and other immunoassays may detect specific microbial antigens. In Molecular Medicine generally Genetic probes identify genus- or species-specific DNA or RNA sequences. Mostly bacteria’s are harmless and beneficial but some are pathogenic. Dichotomous keys and diagnostic tables form the backbone of everyday identification, Standardization of methods for characterizing tests, the development of multiple inoculation apparatus, and the use of mass cultures will enable more reliable tests to be carried out and more strains to be tested. There are rapid methods for bacterial identifications, confirmations, and tracks contaminant sources of all pathogenic, indicator, spoiler organisms, and other environmental isolates using the latest technologies. The global microbial identification market is estimated at $896.5 million by the end of 2014 and is expected to grow at a CAGR of 5.9% from 2014 to 2019, to reach $1,194.1 million by 2019.
- Track 3-1Mass spectrometry techniques
- Track 3-2By metabolism
- Track 3-3Sugar fermentation test
- Track 3-4Litmus milk test
- Track 3-5 Indole production test
- Track 3-6Methyl Red test
- Track 3-7Citrate utilization test
- Track 3-8By differential staining
- Track 3-9Serological methods
- Track 3-10By protein and nucleotide analysis
- Track 3-11Phylogenetic Approach
- Track 3-12Based on resistance
- Track 3-13By Cultural characteristics
- Track 3-14By extra-cellular characters
- Track 3-15 Brobing and amplification tests
- Track 3-16Cytometric based antimicrobial resistance techniques
- Track 3-17Antigen and antibody detection tests
- Track 3-18Advanced PCR techniques
- Track 3-19 Microarray analysis
- Track 3-20 Bioanalytical sensors and Biodetection
- Track 3-21Nanotechnology methods for bacterial detection
- Track 3-22Biomarker studies
- Track 3-23Based on size
- Track 3-24based on shape
- Track 3-25Nipah virus
Occupational epidemiology is of great importance in clinical epidemiology and of occupational hygiene since it provides powerful and good information to understand the causes and determinants of work related ill-health, to help establish what steps should be taken to reduce occupational risks, and to evaluate interventions for the benefits of workers, and of the community in a bigger manner. Many organisms live in and on our bodies which are normally harmless or even helpful, but under certain conditions, some organisms may cause disease. Some infectious diseases can be passed from person to person.
It introduces the basic methods for infectious disease epidemiology and case studies of important disease syndromes and entities. Methods include definitions and nomenclature, outbreak investigations, disease surveillance, case-control studies, cohort studies, laboratory diagnosis, molecular epidemiology, dynamics of transmission, and assessment of vaccine field effectiveness. Case-studies focus on acute respiratory infections, diarrheal diseases, hepatitis, HIV, tuberculosis, sexually transmitted diseases, malaria, and other vector-borne diseases. The IDD market is poised to reach $18,156.2 million by 2019 from $12,422.8 million in 2014, at a CAGR of 7.9% from 2014 to 2019.
Meningitis is an acute inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges. The inflammation may be caused by infection with viruses, bacteria, or other microorganisms, and less commonly by certain drugs. Meningitis can be life threatening because of the inflammation's proximity to the brain and spinal cord. The common symptoms are headache and neck stiffness associated with fever, confusion or altered consciousness, vomiting, and an inability to tolerate light (photophobia) or loud noises (phonophobia).There are about 464,000 deaths in 1990 and 303,000 deaths in 2013.
- Track 4-1Next generation sequencing
- Track 4-2Tick-borne encephalitis virus
- Track 4-3ick-borne hemorrhagic fever viruses
- Track 4-4Crimean-Congo hemorrhagic fever virus
- Track 4-5Ebola
- Track 4-6Zika
- Track 4-7tularemia
- Track 4-8anthrax
- Track 4-9smallpox
- Track 4-10zoonoses
- Track 4-11chikungunya
- Track 4-12Dengue
- Track 4-13SARS and MERS
- Track 4-14SARS coronavirus
- Track 4-15Rabies
- Track 4-16Listeriosis, Neisseria, Gonorrhea, and Meningitis
- Track 4-17Sexually Transmitted Diseases
- Track 4-18Opportunistic infections and complications
- Track 4-19Food poisoning and wound infections
- Track 4-20 Gastroenteritis, urinary tract infections, and neonatal meningitis
- Track 4-21Salmonellosis and shigellosis
- Track 4-22HIV/AIDS
- Track 4-23Sexually Transmitted Diseases
- Track 4-24Sexually Transmitted Infections
- Track 4-25Flu
- Track 4-26Influenza
- Track 4-27Multidrug-resistant tuberculosis (MDR-TB)
- Track 4-28Parvovirus
Many infectious bacteria forms biofilms with which its pathogenic nature increases. The vast majority of these compounds exert their antibiofilm properties through disruption of "quorum sensing," a common means of intercellular communication in bacterial communities that allows coordinated expression of virulence factors and facilitates formation of the complex architecture of mature bacterial biofilms. Certain pathogens like Pseudomonas syringe injects virulence in plant host causing diseases. For the Diagnosis of Pathogenic microorganisms Direct Examination and Techniques includes Immunofluorescence, immuno-peroxidase staining, and other immunoassays may detect specific microbial antigens. Genetic probes identify genus- or species-specific DNA or RNA sequences.
Forensic evidence involves application of forensic science, technology or "forensics", in order to identify the scene of an accident, specific objects from the trace evidence and often at a crime scene. It is usually submitted to court, which are obtained by scientific methods like by blood test, DNA test. Diagnostic Pathology deals with examination of body tissues and their examination. Microscopical study of abnormal tissue development, disease determination, histopathology of lesions and sometimes post-mortem. It does research on critical diagnosis in surgical pathology.
Antibiotic resistant microorganisms have become a brewing problem to our nation. A report states that about 2 million people get sick and 23,000 dies per year because of these microorganisms. The annual cost for the medical expenses were up to $35 billion and another $35 billion was lost in productivity.
- Track 5-1Oral vaccine platform for class A bacterial agents
- Track 5-2Models for Studying Bacterial Pathogenesis
- Track 5-3Strategies for Identifying Bacterial Pathogenicity Genes
- Track 5-4Genetic Determinants of Bacterial Pathogenicity
- Track 5-5Fimbrial Adhesins
- Track 5-6Biofims
- Track 5-7Poisoning the Host by Toxins
- Track 5-8Toxins Acting on Intracellular Targets
- Track 5-9Mechanisms of Bacterial Entry Into Host Cells
- Track 5-10The Bacterial Life in a Vacuole
- Track 5-11The Bacterial Life in the Cytosol
- Track 5-12Bacterial Evasion of Host Defences
- Track 5-13Bacterial Resistance to Antimicrobial Peptides
- Track 5-14Molecular and Cellular Mechanisms
- Track 5-15Mechanisms of bacterial pathogenicity
- Track 5-16Infections in specific tissue
- Track 5-17Bacterial defense phagocytosis, immune responses
- Track 5-18 Antimicrobial agents infectious diseases
- Track 5-19 Pneumococcal vaccine
- Track 5-20 Gastroenteritis and Pertussis
- Track 5-21 Tuberculosis and respiratory diseases
- Track 5-22Host Susceptibility
- Track 5-23Bacterial Infectivity
- Track 5-24Genetic and Molecular Basis for Virulence
- Track 5-25Host-mediated Pathogenesis
- Track 5-26Intracellular Growth
- Track 5-27Virulence Factors
- Track 5-28Pathogenic susceptibility
- Track 5-29Bacteria-Induced Host Cell Death
Humans are associated with microorganisms, as they even colonize in the body like S.aureus in the upper respiratory tract but it may not be harmful to the host and Microinflammation is a body’s defensive response towards an invading microorganism as an effort for self-protection to eradicate harmful stimuli. There are innate immune systems (primary defense mechanism) and adaptive immune system (secondary defence mechanism). Immunogenetics is a subspeciality of medicine that studies the relationship between genetics and immunology. Immunogenetics helps in understanding the pathogenesis of several autoimmune and infectious diseases. The effect of pathogen on host not only depends upon the virulence factor but also depend upon the host’s genetic background. Some species shows innate susceptibility to pathogen not with host like syphilis, gonorrhoea, measles and poliomyelitis act on humans alone. The anatomical defense includes penetration of bacteria through the cut, puncture or scrap on the skin. There are some others like phagocytosis, inflammation through which bacteria can enter the host. Cell mediated immunity cytotoxic T lymphocytes, and the release of various cytokines in response to an antigen.CD4 cells. For a good and proper health conditions, there is a need to improve immune systems. In the total adult population of US only 3% are able to manage the stress (10%), energy (15%) and sleep (11%) and a compromised immune system simultaneously.
- Track 6-1Potential activity of hydroxychavicol against pathogenic bacteria
- Track 6-2Host Genetic Factors
- Track 6-3Natural killer cells
- Track 6-4immune system of bacteria and archaea
- Track 6-5virus resistance in natural microbial communities
- Track 6-6immune defense against bacterial infection
- Track 6-7Antimicrobial defense and persistent infection in insects
- Track 6-8The role of Toll-like receptors
- Track 6-9microbial effector molecules subvert plant immunity
- Track 6-10Antimicrobial peptides of multicellular organisms
- Track 6-11natural effectors of the innate immune system
- Track 6-12mucosal defense in health and disease
- Track 6-13Specific Immune Responses
- Track 6-14Nonspecific Immune Responses
- Track 6-15Immunologic basis of cow milk induced hypersensitivities
- Track 6-16 Adaptive immune interaction in gut inflammation
- Track 6-17Cellular & Molecular defects in human B cell development
- Track 6-18Immunobiology of peanut allergy and its treatment: A prototype
- Track 6-19 Generation and characterization of intestinal CD8+ Regulatory T cell lines
- Track 6-20Meningococcal meningitis
- Track 6-21 Immunology of Infections
- Track 6-22 Respiratory pathogen inducing apoptosis
- Track 6-23Postoperative surgical site bacterial infections and drug susceptibility
- Track 6-24Contribution of pathogenic bacteria to GI symptoms in parasite-free patients
- Track 6-25Natural Barriers
- Track 6-26Innate immune defenses in the intestinal tract
Diagnostic Pathology involves with examination of body tissues and their examination. Microscopical study of abnormal tissue development, disease determination, histopathology of lesions and sometimes post-mortem. It does research on critical diagnosis in surgical pathology. Many diseases are associated with infectious pathogens. A pathogen predisposes to diseases states but may not cause disease. It may cause disease only in combinations (toxins exposure).Any disease causing gene that reduces survival and reproduction will eliminate itself over a number of generations therefore genetic diseases are self-extinguishing. For example, genes that encode sickle cell anaemia are maintained and persist down generations, as these genes protect against malaria, which kills millions worldwide every year. About 70% deaths in US results from chronic diseases and the treatment accounting 75% of all US healthcare costs (amounting to $ 1.7 trillion in 2009).
- Track 7-1Sexually Transmitted Bacterial Infections
- Track 7-2Biological Control of Plant Pathogen
- Track 7-3Multi-pathogen waterborne diseases
- Track 7-4Emerging Microbes & Infections
- Track 7-5Bacterial Urinary Tract Infections
- Track 7-6Hookworm-malaria coinfection
- Track 7-7Bacteriophage coinfection
- Track 7-8Skin Infections
- Track 7-9 Foodborne Bacterial Infections
- Track 7-10Microbial communities & interactions
- Track 7-11 Biofilms
- Track 7-12Microbial genomics
- Track 7-13Molecular epidemiology and pathogenesis
- Track 7-14Bacterial respiratory infections
- Track 7-15Risk Factors for Bacterial Infections
- Track 7-16Wound and Skin Infections
During the past 10 years, genomics based approaches have had a profound impact on the field of microbiology and our understanding of microbial species. Because of their larger genome sizes, genome sequencing efforts on fungi and unicellular eukaryotes were slower to get started than projects focused on prokaryotes; however, today there are a number of genome sequences available from both of these groups of organisms that have led to significant improvements in overall sequence annotation and also shed considerable light on novel aspects of their biology. Molecular systems biology is an integrative discipline that seeks to explain the properties and behaviour of complex biological systems in terms of their molecular components and their interactions. Systems biology is the computational and mathematical modeling of complex biological systems. According to the World Health Organization more than 1 million people acquire a sexually transmitted infection (STI) every day and an estimated 500 million people become ill with Chlamydia, gonorrhoea, syphilis or trichomoniasis every year. Approximately 40% of the bacterial species that have been targeted for genome analysis represent important human pathogens. Approximately 40% of the bacterial species that have been targeted for genome analysis represent important human pathogens. Using a whole genome shotgun approach, Tyson et al. (2004) were able to reconstruct two almost complete genome sequences of Leptospirillum group II and Ferro plasma type II and the partial sequence of three other species from a low complexity acid mine drainage biofilm growing underground within a pyrite or body.
- Track 8-1Genetic and Evolutionary Computing
- Track 8-2Genome Mapping and Genomics in Microbes
- Track 8-3 Next Generation DNA Led Technologies
- Track 8-4Microarray Data Analysis
- Track 8-5 QSAR and Molecular Modeling
- Track 8-6 Systems Biology and Bioinformatics
- Track 8-72-D PAGE Map Analysis
- Track 8-8Analysis of Large and Complex Data
- Track 8-9Recent Advances in Natural Computing
Global Review of Microbial Testing in the Industrial Market (IMMR-4) is a new, extensively researched analysis of the sizable market for microbiological testing in the industrial market. IMMR-4 tracks and compares microbiology test volumes, market values and methods used by companies in the production of safe and wholesome products that meet label claims. IMMR-4 includes global test volumes and growth in industrial bacteriology with further analysis of market sectors, geographic regions, test methods, organisms tested and sample sources. Current market values are detailed as well as projected through 2019. With five-year projections of both testing volumes and market value, IMMR-4 provides critical input to strategic planning. Synthetic genomics is useful for the synthesis of DNA. It gives the methods which are the combination of chemical and computational techniques. By this combination of methods the work which is almost impossible by using conventional techniques became easier. It is possible to design and assemble the whole genome by using synthetic genomics. Applied microbiology is a branch deals with application of microorganisms in the field of science for the production of human beneficial products such as medicines, antibiotics, vaccines, enzymes, biotechnological engineered products and also in food technology as fermentation products.
Chemical and biochemical engineers engage in a wide variety of activities that benefit the global community. Fuel cells, solar energy, and bio renewable fuels (e.g., biodiesel or ethanol) fall within the realm of chemical engineering. Bioremediation occurs when prokaryotes clean up a polluted environment through the natural breakdown of pollutants. Bioremediation can remove oil, some pesticides, fertilizers, and toxic chemicals, such as arsenic, from the environment. Germicidal UV irradiation may be an effective approach for reducing fungal contamination within AHUs (air handling units). The use of germicidal UV lamps in AHUs resulted in significantly lower levels of fungal contamination in the fiberglass insulation lining of study floor AHUs than in the insulation of control floor units. Loop mediated isothermal amplification (LAMP) of DNA has emerged as an alternative to the use of PCR based methods not only in food safety testing but also in a wide array of application. There are many biogeochemical cycles that are currently being studied for the first time as climate change and human impacts are drastically changing the speed, intensity, and balance of these relatively unknown cycles. These newly studied biogeochemical cycles include the mercury cycle, and the human caused cycle of atrazine, which may affect certain species.
- Track 9-1 Exploitation of Bacteria by Humans
- Track 9-2 Role of Metal Nanoparticles
- Track 9-3 Molecular techniques for biotechnological products
- Track 9-4Downstream processing
- Track 9-5Monitoring of released organisms and Microbial metabolism and physiology
- Track 9-6Biotransformation, Biodegradation and Bioremediation
Pathogenic bacteria are inflamative bacteria which are capable of causing disease when enters into the body which can spread through water, air, soil and also through physical contact. Mostly bacteria’s are harmless and beneficial but some are pathogenic. The global medical and clinical microbiology market is valued at $6,727.29 million in 2014 and is expected to grow at a CAGR of 13.03% between 2014 and 2019. Increasing disease burden of infectious diseases and increased funding for healthcare expenditure are the important growth drivers for this market during the forecast period.
The pharmaceuticals application segment accounted for the largest share of the microbiology market in 2014, while the food application segment is expected grow at the highest CAGR between 2014 and 2019 in the global microbiology market.
The medical and clinical microbiology market is segmented on the basis of products into consumables and instruments. The consumables product segment is further sub segmented into kits and reagents. The instruments segment is sub segmented into automated microbiology instruments, laboratory instruments, and microbiology analyzers. The automated microbiology instruments are expected to grow at the highest growth rate in the instruments segment. The incubators are expected to grow at the highest growth rate in the laboratory instruments market. Mass spectrometers, are expected to grow at the highest growth rate in the microbiology analyzers segment. In the consumables segment kits are expected to account for the largest share and expected to grow at the highest growth rate during the forecast period.
The respiratory diseases segment accounted for the largest share of the medical and clinical microbiology market in 2014. This application segment is expected to grow at the highest CAGR between 2014 and 2019 in the clinical microbiology market.
The geographic analysis revealed that North America accounted for the largest share of the global clinical microbiology market in 2014. The Asian regional segment, on the other hand, is expected to register a double-digit growth rate from 2014 to 2019, owing to the increased healthcare spending in this region.
- Track 10-1Bacterial STDs
- Track 10-2Bacterial metabolism and normal flora
- Track 10-3Medical mycology & Medical parasitology
- Track 10-4Antimicrobial treatment from Bench-top to Clinic, gene silencing and chemotherapy
- Track 10-5 Genomics, clinical microbiology and virology
- Track 10-6Microbial strains & antibiotic applications
- Track 10-7 Bacterial types and complexity
- Track 10-8 Bacteria and Probiotics
Vaccination is a process of administration of an antigenic material (vaccine) into a living mechanism. The clinical effect desired is to cause stimulation of an individual's immune system in order to develop an adaptive immunity against the pathogen constituting the vaccine. Vaccination is the most effective method of prevention for infectious diseases. Vaccine Adjuvants are components which potentiate the immune system and accelerate the immune responses to an antigen. It can also be termed as an immunologic adjuvant. These components act to induce, prolong, and enhance antigen-specific immune responses when used in combination with specific vaccine antigens.
Antimicrobial is the agent that kills or restricts the bacterial growth. To fight against the potential bacteria now-a-days, the manufacturing companies are coming up with more advanced antimicrobial liquids/soaps/sanitizers.
Immunization/Vaccination is one of the most cost effective public health interventions to date, saving millions of lives1 and protecting countless children from illness and disability. As a direct result of immunization, polio is on the verge of eradication. Deaths from measles, a major child killer, declined by 71 per cent worldwide and by 80 per cent in sub Saharan Africa between 2000 and 2011.2 And 35 of 59 priority countries have eliminated maternal and neonatal tetanus.
Immunization has not yet realized its full potential, however. As of end 2013, 21.8 million children under 1 year of age worldwide had not received the three recommended doses of vaccine against diphtheria, tetanus and pertussis containing vaccine (DTP3), and 21.6 million children in the same age group had failed to receive a single dose of measles containing vaccine. Given an estimated annual cohort of 133.6 million surviving infants, an additional 11.2 million children would need to have been reached during 2013 to attain 90% DTP3 coverage globally.
One third of the world’s population is infected with TB. In 2013, 9 million people around the world became sick with TB disease. There were around 1.5 million TB related deaths worldwide. TB is a leading killer of people who are HIV infected. A total of 9,582 TB cases (a rate of 3.0 cases per 100,000 persons) were reported in the United States in 2013. Both the number of TB cases reported and the case rate decreased; this represents a 3.6% and 4.3% decline, respectively, compared to 2012.
- Track 11-1Measles and mumps
- Track 11-2 Coinfections
- Track 11-3Yellow fever
- Track 11-4Schistosomiasis
- Track 11-5Probiotics
- Track 11-6Human microbiome
- Track 11-7 Advancement in T-cell therapies
Infectious diseases are those which are caused by bacteria like E.coli, Salmonella, H.pylori, N.gonorrhoeae, N.meningitidis, S.aureus, and S.bacteria. It includes diseases like pneumonia, meningitis, gastroenteritis, urinary tract infections. Case Reports in Clinical Pathology supports the diagnosis of disease using laboratory testing of blood, tissues, and other body fluids. There are types of specimens used clinical pathology. They are blood, urine, sputum, feces, and other body fluids. It deals with women's complaints gynaecological diseases, fertility, pregnancy, '.Pathology (from the Ancient Greek roots of pathos (πάθος), meaning "experience" or "suffering", and -logia (-λογία), "an account of") is a significant component of the causal study of disease and a major field in modern medicine and diagnosis. Pathology is a branch of medical science primarily concerning the examination of organs, tissues, and bodily fluids in order to make a diagnosis of disease.
The drugs used to treat such bacterial infections are called Antibiotics. Especially in US about $ 44.68 billion is expected to reach by 2016.In the period of 2005-2011, there is a growth rate of 6.6% annually. The manufacturing of antibiotics has increased gradually these days, so global demand for aminoglycoside antibiotics is about 79%, pencillin 8%, tetracyclines 4%, erythromycin 7%, streptomycin 1% and chloramphenicol shares about 1% in the antibiotic market globally. Certain bacteria provide benefits to plant including tolerance to temperature stress, salty soils, drought etc. so, there developed microbial seed and plan treatments to confer these stress conditions. It was reported that seed treatment market is trying to reach $ 6 billion by 2020 as it used to be $ 3.6 billion in 2003.
The consumables, equipment and technology markets in the Bacteriology and Microbiology industry comes around nearly $7.7 billion in 2012. This total is expected to grow from $8.5 billion in 2013 to $11.4 billion in 2018, with a compound annual growth rate (CAGR) of 6.1% for the five-year period, 2013 to 2018.
- Track 12-1Review and debate on latest discoveries in Bacteriology
- Track 12-2 Innovative vaccine manufacturing technologies using bioreactors
- Track 12-3 Designing tools for Bacterial Infections and Market Analysis
- Track 12-4 Involvement of Bioprocess during Vaccine production for Infectious Diseases
- Track 12-5 Importance of Computational Biology for Target Drugs and Market Analysis
- Track 12-6 Case reports from vaccine Manufacturers
Enterpreneurs from any field can exhibit their products and can give a presentation on their products which should be helpful in business development and marketing.